Thiola Ec Tablet, Delayed Release
Product Images NDC 0178-0902

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Thiola Ec (NDC 0178-0902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mission Pharmacal Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Thiola Ec 100mg Tablets Label V1

Label for Thiola EC (tiopronin) delayed-release tablets, 100 mg strength. This prescription oral tablet package contains 300 tablets. The label shows the NDC 0178-0902-01 and mentions distribution by Travere Therapeutics, Inc. Dosage instructions and storage conditions are partially visible.*

FDA Label Image

Thiola Ec 300mg Tablets Label V2

Thiola EC 300 mg delayed-release tablets label showing the proprietary and generic name tiopronin. The label indicates a quantity of 90 tablets, Rx only, distributed by Travere Therapeutics, Inc., and manufactured by Mission Pharmacal Company. It includes storage instructions and a barcode.*

FDA Label Image

Tiopronin Chemical Structure (Thiola Ec Chem Struct)

Chemical structure diagram of tiopronin, showing its molecular formula with functional groups including a thiol (SH) and carboxylic acid (COOH).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.